An otherwise normal female presents with symptoms of flatulent dyspepsia. She was started on proton pump inhibitors, which controlled her symptoms. The next step in management of this condition should be:
**Core Concept**
Proton pump inhibitors (PPIs) are effective in controlling symptoms of flatulent dyspepsia, which is often associated with gastroesophageal reflux disease (GERD). However, the underlying pathophysiology of dyspepsia involves impaired gastric emptying and increased sensitivity to gastric distension.
**Why the Correct Answer is Right**
The next step in management would be to investigate the underlying cause of dyspepsia using a test that evaluates gastric emptying and motility, such as a gastric emptying study. **Gastric emptying studies** are often performed using a radionuclide or a breath test to assess the rate at which the stomach empties its contents into the small intestine. This is particularly useful in patients who do not respond to PPIs or have persistent symptoms.
**Why Each Wrong Option is Incorrect**
**Option A:** Starting a histamine-2 receptor antagonist (H2RA) would be a redundant choice, as PPIs are already being used to control symptoms.
**Option B:** Prescribing a prokinetic agent like metoclopramide would be an appropriate choice for patients with gastroparesis or delayed gastric emptying, but not in this scenario where PPIs have controlled symptoms.
**Option C:** Ordering an upper endoscopy would be more relevant in cases of suspected peptic ulcer disease or esophageal cancer, rather than in a patient with controlled dyspepsia symptoms.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that PPIs only mask symptoms of GERD and do not address the underlying pathophysiology, which involves impaired gastric emptying and increased sensitivity to gastric distension.
**Correct Answer:** C.